Literature DB >> 7851540

Binding of progastrin fragments to the 78 kDa gastrin-binding protein.

G S Baldwin1.   

Abstract

The non-selective gastrin/cholecystokinin receptor antagonists proglumide and benzotript inhibit colon carcinoma cell proliferation by binding to the 78 kDa gastrin-binding protein (GBP) (Baldwin, Proc. Natl. Acad. Sci. USA, 91 (1994) 7593-7597). However, although most colon carcinoma cell lines synthesize progastrin, production of mature amidated gastrin17 has not been observed. In order to define the structural requirements for the binding of gastrin to the GBP the affinities of various fragments of amidated and C-terminally extended gastrin17 for the GBP have been measured. The results indicate that the GBP recognizes both N- and C-termini of gastrin17. Moreover since C-terminal amidation is not a prerequisite for binding of gastrin to the GBP, the GBP is a potential target for the autocrine effects of progastrin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7851540     DOI: 10.1016/0014-5793(95)00017-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation.

Authors:  T J Koh; G J Dockray; A Varro; R J Cahill; C A Dangler; J G Fox; T C Wang
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

2.  Processing and proliferative effects of human progastrin in transgenic mice.

Authors:  T C Wang; T J Koh; A Varro; R J Cahill; C A Dangler; J G Fox; G J Dockray
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

3.  Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis.

Authors:  T J Koh; C J Bulitta; J V Fleming; G J Dockray; A Varro; T C Wang
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

4.  A comparison of the therapeutic effectiveness of gastrin neutralisation in two human gastric cancer models: relation to endocrine and autocrine/paracrine gastrin mediated growth.

Authors:  S A Watson; T M Morris; A Varro; D Michaeli; A M Smith
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

Review 5.  Gastrin, gastrin receptors and colorectal carcinoma.

Authors:  G S Baldwin; A Shulkes
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

6.  Progastrin and cyclooxygenase-2 in colorectal cancer.

Authors:  Peter C Konturek; Władysław Bielanski; Stanislaw J Konturek; Artur Hartwich; Piotr Pierzchalski; Macien Gonciarz; Krzysztof Marlicz; Teresa Starzynska; Monika Zuchowicz; Zbigniew Darasz; Jens P Götze; Jens F Rehfeld; Eckhart G Hahn
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

7.  Use of interfering RNA to investigate the role of endogenous gastrin in the survival of gastrointestinal cancer cells.

Authors:  A M Grabowska; J Hughes; S A Watson
Journal:  Br J Cancer       Date:  2007-01-30       Impact factor: 7.640

8.  The G-protein coupled receptor 56, expressed in colonic stem and cancer cells, binds progastrin to promote proliferation and carcinogenesis.

Authors:  Guangchun Jin; Kosuke Sakitani; Hongshan Wang; Ying Jin; Alexander Dubeykovskiy; Daniel L Worthley; Yagnesh Tailor; Timothy C Wang
Journal:  Oncotarget       Date:  2017-06-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.